TGFβ-mediated IL-11 and PTHrP by the cancer cells leads to increased expression of receptor activator of nuclear factor kappa-B ligand (RANKL) at the osteoclast cell surface, further enhancing progenitor cell differentiation into osteoclasts and bone demineralization [159, 160]. The gene discussed is TNFSF11; the disease is cancer.